Compare RPID & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPID | NVX |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | Australia |
| Employees | N/A | 202 |
| Industry | Medical Specialities | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.3M | 191.3M |
| IPO Year | 2021 | N/A |
| Metric | RPID | NVX |
|---|---|---|
| Price | $4.31 | $0.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | 190.3K | ★ 731.1K |
| Earning Date | 04-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $28,051,000.00 | N/A |
| Revenue This Year | $19.91 | $165.90 |
| Revenue Next Year | $21.68 | $1,344.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 24.57 | N/A |
| 52 Week Low | $1.86 | $0.81 |
| 52 Week High | $4.94 | $3.86 |
| Indicator | RPID | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 47.03 |
| Support Level | $3.03 | $0.83 |
| Resistance Level | $4.46 | $1.45 |
| Average True Range (ATR) | 0.33 | 0.06 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 70.48 | 63.96 |
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.